Dr. David Mark Shavelle, MD

Dr. Shavelle practices at Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System.

Dr. Shavelle's NPI, 1154315919, was assigned on September 8, 2005. Dr. Shavelle graduated from David Geffen School of Medicine at UCLA in 1991. Dr. Shavelle holds California license A54834.

Dr. Shavelle's primary practice is Long Beach Medical Center, at 2801 Atlantic Ave, Long Beach, CA 90806 in Los Angeles County. The practice phone is (562) 933-2000.

Dr. Shavelle's primary practice is Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System. The medical group on file is MemorialCare Medical Group. Dmand AI also links Dr. Shavelle to 1 more group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shavelle practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Shavelle's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Shavelle is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Shavelle is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and leg revascularization among the conditions Dr. Shavelle treats.

CMS data shows 824 Medicare services from Dr. Shavelle across 13 procedure codes in 2024, for 360 Medicare patients. Medicare paid $71,769 for them.

CMS counts 360 Medicare patients who saw Dr. Shavelle in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shavelle's median patient age at 66, with 49% women.

In 2024, Dr. Shavelle wrote 1,133 Medicare Part D claims for 181 patients. 75% of them were for generic drugs. CMS names the drug for 933 of them, across 25 drugs with 11 or more claims each, at $251,769 in total drug cost. In 2023, CMS named 673 claims across 21 drugs.

Dr. Shavelle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shavelle as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 112 papers to Dr. Shavelle, published from 2005 to 2024. 2015 was the busiest year, with 8. The most frequent topics are Calcinosis, Tomography, X-Ray Computed and Aortic Valve. Dr. Shavelle has published most often in Am J Cardiol. Dr. Shavelle's most frequent co-authors are Matthew J. Budoff, MD, Kevin Douglas O'Brien and James Niemann, MD.

Dmand AI links Dr. Shavelle to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Heart Failure, Heart Diseases and Angina, Unstable.

CMS Open Payments shows 281 general payments to Dr. Shavelle from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Abbott Laboratories paid the most, $79,709.

Dmand AI lists 4 awards for Dr. Shavelle, most recently Top Doctors:LA Area in 2013.

Dr. Shavelle graduated from David Geffen School of Medicine at UCLA in 1991. Dr. Shavelle is a member of ACC.

Dr. Shavelle is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.